A Single-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 08 Aug 2013
At a glance
- Drugs Esketamine (Primary) ; Triazolam
- Indications Pain
- Focus Pharmacokinetics
- 28 May 2013 Planned end date changed from 1 Apr 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 01 May 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Feb 2013 New trial record